Omeros touts positive trial for eye surgery therapy; Pozen shares jump on licensing pact;

@FierceBiotech: Labopharm slashes staff, pushes strategic review. News | Follow @FierceBiotech

@JohnCFierce: Looks like Peptimmune is heading off into the sunset. Article | Follow @JohnCFierce

> Seattle-based Omeros says that its experimental therapy for patients undergoing cataract surgery proved promising in a mid-stage study, paving the way to a pivotal Phase III trial. Story

> Shares of Pozen jumped five percent this morning after it announced that it had licensed some Latin American rights to its migraine drug MT400 to a unit of J&J for an undisclosed upfront fee and milestones. Report

> Quintiles says that it has shelved financing plans outlined earlier in the month. Story

> After seeing its share price shoot up Prana Biotechnology in Australia is raising a little more than $6 million through a private placement. Prana release

> RTU and Sucampo Manufacturing and Research AG inked a licensing agreement to develop, manufacture, and commercialize Unoprostone (Rescula) in regions excluding Japan, Taiwan, Republic of Korea, the People's Republic of China and North America. Report

Pharma News

> With Sanofi-Merck deal off, look for animal health M&A. Report

> Payers may balk at Makena pricing, KV says. Story

> Bill would require Medicare to pay for off-label meds. Article

> SC jury finds J&J letter violated consumer laws. Story

> Pfizer chiefs new and old get big bumps in pay. News

> Pfizer in talks with feds on Protonix rebate charges. Report

Drug Delivery News

> Tekmira sues RNAi drug-delivery partner Alnylam. Report 

> Puzzle solved to deliver RNA drugs into brain. News

> MRI guides cancer drug directly to liver. Story 

> Startup with "spidersilk" for drug delivery raises $7M. Item 

> OncoSec, cancer drug delivery firm, taking form. Article 

> More cancer-killing gold found in gold nanoparticles? Story

Medical Device News

> ACT study aims to demonstrate safety, efficacy of TEMPASURE catheter. News

> Ex-Exactech rep to pay $56K for role in kickback scheme. Story

> Terumo unit enters consent decree, gives up $35M in profits. Article

> St. Jude shares up on JP Morgan analyst note. Report 

> ReGen says it's fed up with FDA's 'agenda,' refuses hearing. News

> Nordion to evaluate TheraSphere in PhIII. Story

> Core Essence raises $11.5M in Series B funding. Article

And Finally... Investigators at Tufts Medical Center say that occasional sex significantly raises the risk of a heart attack. Story